RAGE (receptor for advanced glycation end products): a central player in the inflammatory response
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Microbes and Infection
- Vol. 6 (13) , 1219-1225
- https://doi.org/10.1016/j.micinf.2004.08.004
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Glycation, Inflammation, and RAGECirculation Research, 2003
- High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritisArthritis & Rheumatism, 2003
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammationNature, 2002
- Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammationJournal of Clinical Investigation, 1999
- RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin PolypeptidesPublished by Elsevier ,1999
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.Journal of Clinical Investigation, 1996
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGINGAnnual Review of Medicine, 1995